Your Article Summary
Angiotech enters license, distribution and supply agreements for fibrin and thrombin technologies with
haemacure corporation
Angiotech Pharmaceuticals, 06/04/09
Angiotech Pharmaceuticals, Inc. , a specialty pharmaceutical and medical device company, announced the completion of a collaboration transaction with Haemacure Corporation, a specialty bio-therapeutics company, relating to certain of Haemacure's proprietary fibrin and thrombin technologies, both of which are currently in development.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer CropScience and FuturaGene sign license agreement for drought tolerance technology in cotton
BayNews International, 12/04/09
Sanofi-aventis enters into an Exclusive Global Licensing Agreement with The Rockefeller University
Sanofi-aventis, 12/04/09
Watson Receives FTC Clearance for Arrow Acquisition
Watson Pharmaceuticals, 12/03/09
Article Search
Sponsor


See Latest Articles


